It is a pharma private limited company based in Calcutta, West Bengal, India, established in 1973.
1973 | Calcutta, West Bengal, India | ActiveSuperb Drugs Pvt Ltd, a active private limited company, was established on 25 June 1973 in Calcutta, West Bengal, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U70109WB1973PTC010840. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹7.25 M.
It upholds a active non-compliant status. Its leadership includes Raj Kamal Kanoria (Director), Ram Balak Sah (Director), Ajay Baral (Director). Past directors included Amit Kumar Sarkar, Tapash Sharma, Arabind Kumar Mishra. It holds ₹7.96 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2014, with the balance sheet filed on 31 March 2014. It is based at 1/3/3D Dum Dum Roadcalcutta, Calcutta, West Bengal, 700002.
U70109WB1973PTC010840
010840
25 June 1973
₹7.50 M
₹7.25 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Superb Drugs Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raj Kamal Kanoria | Director | 14 Jan 2016 | Current |
| Ram Balak Sah | Director | 01 Dec 2014 | Current |
| Ajay Baral | Director | 03 Nov 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 May 2014 | Past |
| Pramod Abcsdd | Director | 01 Dec 2014 | Past |
| Pramod Abcsdd | Director | 02 Jul 2012 | Past |
| Pramod Abcsdd | Director | 02 Apr 2011 | Past |
| Pramod Abcsdd | Additional Director | 03 Nov 2014 | Past |
| Pramod Abcsdd | Additional Director | 10 Mar 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Superb Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Superb Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹79,620,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Aug 2009 | Idbi Bank Ltd. | ₹4.75 Cr | Open |
| 24 Apr 2004 | United Bank Of India | ₹2.86 Cr | Open |
| 28 May 2002 | United Bank Of India | ₹3.50 M | Open |
Explore comprehensive loan charge details -
Superb Drugs has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Superb Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Superb Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Raj Kamal Kanoria was appointed as a Director was appointed as a Director on 14 Jan 2016 & has been associated with this company since 9 years 10 months . was recorded as a recent event.
Ram Balak Sah was appointed as a Director was appointed as a Director on 01 Dec 2014 & has been associated with this company since 10 years 11 months . was recorded as a recent event.
Ajay Baral was appointed as a Director was appointed as a Director on 03 Nov 2014 & has been associated with this company since 11 years 27 days . was recorded as a recent event.
The activity Superb Drugs Pvt Ltd last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records. was completed.
The activity Superb Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Kolkata. was completed.
A charge with Idbi Bank Ltd. amounted to Rs. 47.50 M with Charge ID 10181224 was registered on 26 Aug 2009. was recorded as a recent event.
The CIN of Superb Drugs Pvt Ltd is U70109WB1973PTC010840.
Superb Drugs Pvt Ltd is headquartered at 1/3/3D Dum Dum Roadcalcutta, Calcutta, West Bengal, 700002.
Superb Drugs Pvt Ltd was incorporated on 25 June 1973.
The current directors of Superb Drugs Pvt Ltd are
The primary industry of Superb Drugs Pvt Ltd is Pharma.
Superb Drugs Pvt Ltd is unlisted.
The authorized capital of Superb Drugs Pvt Ltd is ₹7.50 M, and the paid-up capital is ₹7.25 M.
The compliance status of Superb Drugs Pvt Ltd is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX